Class III · Low risk
NEXLIZET (bempedoic acid and ezetimibe)
Failed dissolution specifications: out-of-specification bempedoic acid dissolution at the 0-month timepoint.
National Drug Code
Is NDC 72426-0818-03 recalled?
Nexlizet · 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72426-818-03)
Yes — this exact package was recalled
2 FDA recalls name the code 72426-0818-03 directly. A recall still applies to particular lot numbers — compare the lot on your package with the FDA notice below, and talk to your pharmacist before stopping a prescribed medication.
- Active ingredient
- Bempedoic Acid and Ezetimibe
- Strength
- BEMPEDOIC ACID 180 mg/1; EZETIMIBE 10 mg/1
- Form
- Tablet, Film Coated · Oral
- Labeler
- Esperion Therapeutics, Inc.
- Type
- Human Prescription Drug
- Product code
- 72426-0818
Recalls naming this package
Class III · Low risk
Nexlizet (bempedoic acid and ezetimibe)
Failed dissolution specifications: below specification results at stability 12-month
Where to find this code. The NDC is printed on the pharmacy label and on the manufacturer's carton, usually as three groups of digits after “NDC”. The last group is the package size — two bottles of the same medicine can differ only in that group, and a recall may cover one but not the other.
Free recall alerts
Know the day your medication is recalled
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.